Por: Fox Business Business November 14, 2023
FOX News medical contributor Dr. Marc Siegel discusses how prepared hospital E.R.s are to treat kids and the side effects of weight loss drugs on 'The Big Money Show.' Novo Nordisk's can reduce the risk of serious heart problems such as heart attack, stroke or death in certain patients by 20%, according to a study published in the New England Journal of Medicine. The study, funded by Novo Nordisk, tested the effects of a weekly... + full article
New York Post USA Life November 14, 2023
can reduce the risk of severe heart problems by 20%, a pivotal study finds, paving the way for applications far beyond weight loss. “It moves from a kind of therapy that reduces body weight to a therapy that reduces cardiovascular events,” said Dr. Michael Lincoff, the... + más
As weight loss drugs' popularity grows, teens turn to Wegovy for help | ABC News
Wegovy, Ozempic can help with heart failure symptoms, study finds | New York Post
The Atlantic USA Opinion October 16, 2023
Can Novo Nordisk’s success really be a problem for the Danish economy?Ben Kothe / The Atlantic; GettyOctober 16, 2023, 7:30 AM ETOver the past couple of years, no new pharmaceutical drug—perhaps no product, period—has had such widespread impact as the diabetes medication... + más
What Are the Duties of A Trustee? | Forbes
Rare silver coin from first Jewish revolt against Roman Empire discovered | Newsweek
Fox Business USA Business August 09, 2023
Fox News medical contributor Dr. Marc Siegel discusses whether weight loss drugs like Ozempic can lower anxiety and depression on 'Varney & Co.' Danish said Tuesday that results from a recent drug trial demonstrated that its highly sought weight loss drug Wegovy also... + más
Novo Nordisk cuts supply of certain Wegovy doses as it faces strong demand | Fox Business
Ozempic faces review over concerns it may trigger suicidal thoughts | New York Post
MarketWatch USA Business August 08, 2023
The positive results represent the first concrete evidence that the new class of weight-loss drugs from Novo Nordisk (ticker: NVO) and Eli Lilly (LLY) offer substantive health benefits beyond weight reduction for overweight or obese patients without diabetes. The results will... + más
The End Of Obesity | Forbes
Use medication, surgery early to treat obesity in kids, new guidance says | Portland Press Herald
New York Post USA Business July 10, 2023
European drug-safety regulators are probing popular weight-loss drug Ozempic after patients reported that the medicine triggered thoughts of suicide and self harm. The European Medicines Agency (EMA) on Monday that a safety committee was probing Novo Nordisk-made weight-loss... + más
Does Medicare cover Ozempic? | WGN-TV
What is Ozempic? Why stars risk ‘old face’ for trendy weight-loss drug | New York Post
Fox Business USA Business May 04, 2023
Fox News medical contributor Dr. Nicole Saphier discusses the dangers of using the diabetes drug Ozempic for weight loss on 'The Big Money Show.' is cutting U.S. supply on certain dose strengths of its highly sought-after weight loss drug Wegovy due to strong demand. ... + más
Novo Nordisk Will Lower Insulin Prices Up To 75%, Following Eli Lilly | Forbes
Wegovy, Ozempic: The barriers to accessing these weight loss drugs | Fox Business
Forbes USA Business March 14, 2023
Topline Pharmaceutical heavyweight Novo Nordisk on Tuesday it is cutting prices for several insulin drugs in the U.S., following a similar move from drugmaker Eli Lilly as healthcare companies come under increasing pressure to lower prices for the lifesaving diabetes medication.... + más
Novo Nordisk to lower insulin prices by 75% | Fox Business
Novo Nordisk to slash U.S. insulin prices by up to 75%, following move by Eli Lilly | CNBC
About iurex | Privacy Policy | Disclaimer |